Transvaginal cholecystectomy

Effect on quality of life and female sexual function

Stephanie Wood, Daniel Solomon, Lucian Panait, Robert L. Bell, Andrew J. Duffy, Kurt E. Roberts

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Importance: Transvaginal cholecystectomy (TVC) is the leading natural orifice transluminal endoscopic surgery to date and has the potential to offer improved cosmesis, less pain, and shorter recovery times for female patients. Objective: To investigate quality of life and female sexual function in our patients undergoing TVC. Design: A prospective cohort study from August 14, 2009, to June 12, 2012, of TVCs performed at our institution to date. Setting: Tertiary academic referral center. Participants: The first 47 consecutive female patients (aged 18-65 years) who received a TVC by a single surgeon. Interventions: A hybrid TVC was performed by a 5-mm umbilical trocar and a 12-mm transvaginal trocar with standard laparoscopic instruments. Main Outcomes and Measures: Quality-of-life index (36-Item Short Form Health Survey) and female sexual function (Female Sexual Function Index) scores. Results: A total of 47 TVCs were performed, with a mean age of 39 years, mean body mass index (calculated as weight in kilograms divided by height in meters squared) of 31, and mean operative time of 65 minutes. No difference was noted in overall female sexual function from preoperatively to 1 and 3months postoperatively. When comparing quality of life preoperatively vs 1 and 3 months postoperatively, there were significant improvements in physical function (P =.02), energy and fatigue (P =.001), emotional well-being (P =.01), pain (P < .001), and general health (P =.03). No significant changes were noted in physical limitations ( P =.18), emotional problems (P =.72), and social function (P =.12). Conclusions and Relevance: In our experience to date, female sexual function is unchanged and quality of life either is unchanged or improves at 1 and 3 months following TVC. Undergoing TVC does not appear to negatively affect female sexual function or quality of life in the short term.

Original languageEnglish (US)
Pages (from-to)435-438
Number of pages4
JournalJAMA Surgery
Volume148
Issue number5
DOIs
StatePublished - May 1 2013
Externally publishedYes

Fingerprint

Cholecystectomy
Quality of Life
Surgical Instruments
Natural Orifice Endoscopic Surgery
Umbilicus
Pain
Operative Time
Health Surveys
Tertiary Care Centers
Fatigue
Body Mass Index
Cohort Studies
Outcome Assessment (Health Care)
Prospective Studies
Weights and Measures
Health

ASJC Scopus subject areas

  • Surgery

Cite this

Wood, S., Solomon, D., Panait, L., Bell, R. L., Duffy, A. J., & Roberts, K. E. (2013). Transvaginal cholecystectomy: Effect on quality of life and female sexual function. JAMA Surgery, 148(5), 435-438. https://doi.org/10.1001/jamasurg.2013.108

Transvaginal cholecystectomy : Effect on quality of life and female sexual function. / Wood, Stephanie; Solomon, Daniel; Panait, Lucian; Bell, Robert L.; Duffy, Andrew J.; Roberts, Kurt E.

In: JAMA Surgery, Vol. 148, No. 5, 01.05.2013, p. 435-438.

Research output: Contribution to journalArticle

Wood, S, Solomon, D, Panait, L, Bell, RL, Duffy, AJ & Roberts, KE 2013, 'Transvaginal cholecystectomy: Effect on quality of life and female sexual function', JAMA Surgery, vol. 148, no. 5, pp. 435-438. https://doi.org/10.1001/jamasurg.2013.108
Wood, Stephanie ; Solomon, Daniel ; Panait, Lucian ; Bell, Robert L. ; Duffy, Andrew J. ; Roberts, Kurt E. / Transvaginal cholecystectomy : Effect on quality of life and female sexual function. In: JAMA Surgery. 2013 ; Vol. 148, No. 5. pp. 435-438.
@article{4d389fce23084c5f8b2cc1445a7b2184,
title = "Transvaginal cholecystectomy: Effect on quality of life and female sexual function",
abstract = "Importance: Transvaginal cholecystectomy (TVC) is the leading natural orifice transluminal endoscopic surgery to date and has the potential to offer improved cosmesis, less pain, and shorter recovery times for female patients. Objective: To investigate quality of life and female sexual function in our patients undergoing TVC. Design: A prospective cohort study from August 14, 2009, to June 12, 2012, of TVCs performed at our institution to date. Setting: Tertiary academic referral center. Participants: The first 47 consecutive female patients (aged 18-65 years) who received a TVC by a single surgeon. Interventions: A hybrid TVC was performed by a 5-mm umbilical trocar and a 12-mm transvaginal trocar with standard laparoscopic instruments. Main Outcomes and Measures: Quality-of-life index (36-Item Short Form Health Survey) and female sexual function (Female Sexual Function Index) scores. Results: A total of 47 TVCs were performed, with a mean age of 39 years, mean body mass index (calculated as weight in kilograms divided by height in meters squared) of 31, and mean operative time of 65 minutes. No difference was noted in overall female sexual function from preoperatively to 1 and 3months postoperatively. When comparing quality of life preoperatively vs 1 and 3 months postoperatively, there were significant improvements in physical function (P =.02), energy and fatigue (P =.001), emotional well-being (P =.01), pain (P < .001), and general health (P =.03). No significant changes were noted in physical limitations ( P =.18), emotional problems (P =.72), and social function (P =.12). Conclusions and Relevance: In our experience to date, female sexual function is unchanged and quality of life either is unchanged or improves at 1 and 3 months following TVC. Undergoing TVC does not appear to negatively affect female sexual function or quality of life in the short term.",
author = "Stephanie Wood and Daniel Solomon and Lucian Panait and Bell, {Robert L.} and Duffy, {Andrew J.} and Roberts, {Kurt E.}",
year = "2013",
month = "5",
day = "1",
doi = "10.1001/jamasurg.2013.108",
language = "English (US)",
volume = "148",
pages = "435--438",
journal = "JAMA Surgery",
issn = "2168-6254",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - Transvaginal cholecystectomy

T2 - Effect on quality of life and female sexual function

AU - Wood, Stephanie

AU - Solomon, Daniel

AU - Panait, Lucian

AU - Bell, Robert L.

AU - Duffy, Andrew J.

AU - Roberts, Kurt E.

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Importance: Transvaginal cholecystectomy (TVC) is the leading natural orifice transluminal endoscopic surgery to date and has the potential to offer improved cosmesis, less pain, and shorter recovery times for female patients. Objective: To investigate quality of life and female sexual function in our patients undergoing TVC. Design: A prospective cohort study from August 14, 2009, to June 12, 2012, of TVCs performed at our institution to date. Setting: Tertiary academic referral center. Participants: The first 47 consecutive female patients (aged 18-65 years) who received a TVC by a single surgeon. Interventions: A hybrid TVC was performed by a 5-mm umbilical trocar and a 12-mm transvaginal trocar with standard laparoscopic instruments. Main Outcomes and Measures: Quality-of-life index (36-Item Short Form Health Survey) and female sexual function (Female Sexual Function Index) scores. Results: A total of 47 TVCs were performed, with a mean age of 39 years, mean body mass index (calculated as weight in kilograms divided by height in meters squared) of 31, and mean operative time of 65 minutes. No difference was noted in overall female sexual function from preoperatively to 1 and 3months postoperatively. When comparing quality of life preoperatively vs 1 and 3 months postoperatively, there were significant improvements in physical function (P =.02), energy and fatigue (P =.001), emotional well-being (P =.01), pain (P < .001), and general health (P =.03). No significant changes were noted in physical limitations ( P =.18), emotional problems (P =.72), and social function (P =.12). Conclusions and Relevance: In our experience to date, female sexual function is unchanged and quality of life either is unchanged or improves at 1 and 3 months following TVC. Undergoing TVC does not appear to negatively affect female sexual function or quality of life in the short term.

AB - Importance: Transvaginal cholecystectomy (TVC) is the leading natural orifice transluminal endoscopic surgery to date and has the potential to offer improved cosmesis, less pain, and shorter recovery times for female patients. Objective: To investigate quality of life and female sexual function in our patients undergoing TVC. Design: A prospective cohort study from August 14, 2009, to June 12, 2012, of TVCs performed at our institution to date. Setting: Tertiary academic referral center. Participants: The first 47 consecutive female patients (aged 18-65 years) who received a TVC by a single surgeon. Interventions: A hybrid TVC was performed by a 5-mm umbilical trocar and a 12-mm transvaginal trocar with standard laparoscopic instruments. Main Outcomes and Measures: Quality-of-life index (36-Item Short Form Health Survey) and female sexual function (Female Sexual Function Index) scores. Results: A total of 47 TVCs were performed, with a mean age of 39 years, mean body mass index (calculated as weight in kilograms divided by height in meters squared) of 31, and mean operative time of 65 minutes. No difference was noted in overall female sexual function from preoperatively to 1 and 3months postoperatively. When comparing quality of life preoperatively vs 1 and 3 months postoperatively, there were significant improvements in physical function (P =.02), energy and fatigue (P =.001), emotional well-being (P =.01), pain (P < .001), and general health (P =.03). No significant changes were noted in physical limitations ( P =.18), emotional problems (P =.72), and social function (P =.12). Conclusions and Relevance: In our experience to date, female sexual function is unchanged and quality of life either is unchanged or improves at 1 and 3 months following TVC. Undergoing TVC does not appear to negatively affect female sexual function or quality of life in the short term.

UR - http://www.scopus.com/inward/record.url?scp=84877850951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877850951&partnerID=8YFLogxK

U2 - 10.1001/jamasurg.2013.108

DO - 10.1001/jamasurg.2013.108

M3 - Article

VL - 148

SP - 435

EP - 438

JO - JAMA Surgery

JF - JAMA Surgery

SN - 2168-6254

IS - 5

ER -